Age-related macular degeneration: A perspective on genetic studies

Eye

Volumn 22, Issue 6, 2008, Pages 768-776

  Patel, N ^a   Adewoyin, T ^a   Chong, N V ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; APOLIPOPROTEIN E; CHEMOKINE RECEPTOR CX3CR1; COMPLEMENT COMPONENT C2; COMPLEMENT FACTOR H; DIPEPTIDYL CARBOXYPEPTIDASE; FIBULIN; FIBULIN 5; G PROTEIN COUPLED RECEPTOR KINASE 5; GELATINASE B; HISTIDINE; HLA ANTIGEN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; MANGANESE SUPEROXIDE DISMUTASE; PEGAPTANIB; RANIBIZUMAB; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TOLL LIKE RECEPTOR 4; TYROSINE; VASCULOTROPIN; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

DRUG TARGETING; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; INFORMATION RETRIEVAL; MEDLINE; PATHOGENESIS; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK FACTOR;

EID: 45449085894     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702844     Document Type: Review

References (97)

1. Friedman DS, O'Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004; 122(4): 564-572.
2. Owen CG, Fletcher AE, Donoghue M, Rudnicka AR. How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom? Br J Ophthalmol 2003; 87(3): 312-317.
3. la Cour M, Kiilgaard JF, Nissen MH. Age-related macular degeneration: epidemiology and optimal treatment. Drugs Aging 2002; 19(2 : 101-133.
4. Smith W, Mitchell P. Family history and age-related maculopathy: The Blue Mountains Eye Study. Aust N Z J Ophthalmol 1998; 26(3 : 203-206.
5. Hyman L, Neborsky R. Risk factors for age-related macular degeneration: an update. Curr Opin Ophthalmol 2002; 13(3): 171-175.
6. Meyers SM. A twin study on age-related macular degeneration. Trans Am Ophthalmol Soc 1994; 92: 775-843.
7. Klein ML, Francis PJ. Genetics of age-related macular degeneration. Ophthalmol Clin North Am 2003; 16(4): 567-574.
8. Seddon JM, Santangelo SL, Book K, Chong S, Cote J. A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am J Hum Genet 2003; 73(4): 780-790.
9. Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of age-related maculopathy. Am J Opthalmol 1997; 123(21): 199-206.
10. Klaver CC, Wolfs RC, Assink JJ, van Duijn CM, Hofman A, de Jong PT. Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol 1998; 116(12): 1646-1651.
11. Seddon JM, Cote J, Page WF, Aggen SH, Neale MC. The US twin study of age-related macular degeneration: Relative roles of genetic and environmental influences. Arch Ophthalmol 2005; 123(3): 321-327.
12. Hammond CJ, Webster AR, Snieder H, Bird AC, Gilbert CE, Spector TD. Genetic influence on early age-related maculopathy: A twin study. Ophthalmology 2002; 109(4): 730-736.
13. De La Paz MA, Pericak-Vance MA, Lennon F, Haines JL, Seddon JM. Exclusion of TIMP3 as a candidate locus in age-related macular degeneration. Invest Ophthalmol Vis Sci 1997; 38(6): 1060-1065.
14. Allikmets R, Shroyer NF, Singh N, Seddon JM, Lewis RA, Bernstein PS et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 1997; 277 (5333):1805-1807.
15. Stone EM, Webster AR, Vandenburgh K, Streb LM, Hockey RR, Lotery AJ et al. Allelic variation in ABCR associated with Stargardt disease but not age-related macular degeneration. Nat Genet 1998; 20 (4): 328-329.
16. Allikmets R, Seddon JM, Bernstein PS, Hutchinson A, Atkinson A, Sharma S et al. Evaluation of the Best disease gene in patients with age-related macular degeneration and other maculopathies. Hum Genet 1999; 104(6): 449-453.
17. Lotery AJ, Munier FL, Fishman CA, Weleber RG, Jacobson SG, Affatigato LM et al. Allelic variation in the VMD2 gene in best disease and age-related macular degeneration. Invest Ophthalmol Vis Sci 2000; 41(6): 1291-1296.
18. Marmorstein L. Association of EFEMP1 with malattia leventinese and age-related macular degeneration: A mini-review. Ophthalmic Genet 2004; 25(3): 219-226.
19. Stone EM, Braun TA, Russell SR, Kuehn MH, Lotery AJ, Moore PA et al Missense variations in the fibulin 5 gene and age-related macular degeneration. N Engl J Med 2004; 351(4): 346-353.
20. Lotery AJ, Baas D, Ridley C, Jones RP, Klaver CC, Stone E et al. Reduced secretion of fibulin 5 in age-related macular degeneration and cutis laxa. Hum Mutat 2006; 27(6): 568-574.
21. Johnson LV, Anderson DH. Age-related macular degeneration and the extracellular matrix. N Engl J Med. 2004; 351(4): 320-322.
22. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 2001; 20(6): 705-732.
23. Johnson LV, Leitner WP, Staples MK, Anderson DH. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp Eye Res 2001; 73(6): 887-896.
24. Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 2000; 14(7 : 835-846.
25. Sivaprasad S, Chong NV. The complement system and age-related macular degeneration. Eye 2006; 20(8): 867-872.
26. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005; 102(20): 7227-7232.
27. Edwards AO, Ritter Iii R, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science 2005; 308: 421-424.
28. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308: 385-389.
29. Zareparsi S, Branham KE, Li M, Shah S, Klein RJ, Ott J et al. Strong association of the Y402 H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet 2005; 77(1): 149-153.
30. Conley YP, Thalamuthu A, Jakobsdottir J, Weeks DE, Mah T, Ferrell RE et al. Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy 10.1093/hmg/ddi204. Hum Mol Genet 2005; 14(14): 1991-2002.
31. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P et al Complement factor H variant increases the risk of age-related macular degeneration. Science 2005; 308(5720): 419-421.
32. Gotoh N, Yamada R, Hiratani H, Renault V, Kuroiwa S, Monet M et al No association between complement factor H gene polymorphism and exudative age-related macular degeneration in Japanese. Hum Genet 2006; 120: 1-5.
33. Lau LI, Chen SJ, Cheng CY, Yen MY, Lee FL, Lin MW et al. Association of the Y402 H Polymorphism in Complement Factor H Gene and Neovascular Age-Related Macular Degeneration in Chinese Patients. Invest Ophthalmol Vis Sci 2006; 47(8): 3242-3246.
34. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K et al Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 2006; 38(4): 458-462.
35. Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 2005; 77(3):389-407.
36. Rivera A, Fisher SA, Fritsche LG, Keilhauer CN, Lichtner P, Meitinger T et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk Hum Mol Genet 2005; 14 (21): 3227-3236.
37. Marx J. Gene offers insight into macular degeneration. Science 2006; 314(5798): 405.
38. Schmidt S, Hauser MA, Scott WK, Postel EA, Agarwal A, Gallins P et al Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 2006; 78 (5): 852-864.
39. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993; 90(20): 9649-9653.
40. Souied EH, Benlian P, Amouyel P, Feingold J, Lagarde JP, Munnich A et al. The ε4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 1998; 125(3): 353-359.
41. Klaver CC, Kliffen M, van Duijn CM, Hofman A, Cruts M, Grobbee DE et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 1998; 63(1): 200-206.
42. Baird PN, Chu D, Guida E, Vu HT, Guymer R. Association of the M55L and Q192R paraoxonase gene polymorphisms with age-related macular degeneration. Am J Ophthalmol 2004; 138(4): 665-666.
43. Zareparsi S, Reddick AC, Branham KE, Moore KB, Jessup L, Thoms S et al. Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center. Invest Ophthalmol Vis Sci 2004, 45(5): 1306-1310.
44. Nowak M, Swietochowska E, Szapska B, Marek B, Wielkoszynski T, Koziol H et al. The apolipoprotein E polymorphism in age related macular degeneration]. Klin Oczna 2004; 106(Suppl 3): 427-428.
45. Gotoh N, Kuroiwa S, Kikuchi T, Arai J, Arai S, Yoshida N et al. Apolipoprotein E polymorphisms in Japanese patients with polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Am J Ophthalmol 2004; 138(4): 567-573.
46. Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 2000; 14(7 : 835-846.
47. Penfold P, Liew S, Madigan M, Provis J. Modulation of major histocompatibility complex class II expression in retinas with age-related macular degeneration. Invest Ophthalmol Vis Sci 1997; 38(10): 2125-2133.
48. Goverdhan SV, Howell MW, Mullins RF, Osmond C, Hodgkins PR, Self J et al. Association of HLA Class I and Class II polymorphisms with age-related macular degeneration 10.1167/iovs.04-0928. Invest Ophthalmol Vis Sci 2005; 46(5): 1726-1734.
49. Seddon JM, George S, Rosner B, Klein ML. CFH gene variant Y402H, and smoking, body mass index environmental associations with advanced age-related macular degeneration. Hum Hered 2006, 61(3): 157-165.
50. Suganthalakshmi B, Anand R, Kim R, Mahalakshmi R, Karthikprakash S, Namperumalsamy P et al. Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Mol Vis 2006; 12 336-341.
51. Rosenfeld PJ, Heier JS, Hantsbarger G, Shams N. Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration. Ophthalmology 2006; 113(4): 632 el.
52. Haines JL, Schnetz-Boutaud N, Schmidt S, Scott WK, Agarwal A, Postel EA et al. Functional candidate genes in age-related macular degeneration: Significant association with VEGF, VLDLR, and LRP6. Invest Ophthalmol Vis Sci 2006; 47(1): 329-335.
53. Lu H, Shu XO, Cui Y, Kataoka N, Wen W, Cai Q et al. Association of genetic polymorphisms in the VEGF gene with breast cancer survival. Cancer Res 2005; 65(12): 5015-5019.
54. Morohashi K, Takada T, Omori K, Suzuki E, Gejyo F. Vascular endothelial growth factor gene polymorphisms in Japanese patients with sarcoidosis 10.1378/chest.123.5.1520. Chest 2003; 123(5): 1520-1526.
55. Esfandiary H, Chakravarthy U, Patterson C, Young I, Hughes AE. Association study of detoxification genes in age related macular degeneration. Br J Ophthalmol 2005; 89(4): 470-474.
56. Hayashi M, Merriam JE, Klaver CC, Zernant J, Bergen AA, Smith RT et al. Evaluation of the ARMD1 locus on 1q25-31 in patients with age-related maculopathy: Genetic variation in laminin genes and in exon 104 of HEMICENTIN-1. Ophthalmic Genet 2004; 25(2): 111-119.
57. Conley YP, Thalamuthu A, Jakobsdottir J, Weeks DE, Mah T, Ferrell RE et al. Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. Hum Mol Genet 2005; 14(14): 1991-2002.
58. Stone EM, Lotery AJ, Munier FL, Heon E, Piguet B, Guymer RH et al. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet 1999, 22(2): 199-202.
59. Guymer RH, McNeil R, Cain M, Tomlin B, Allen PJ, Dip CL et al. Analysis of the Arg345Trp disease-assoviated allele of the EFEMP1 gene in individuals with early onset drusen or familial age-related macular degeneration. Clin Exp Ophthalmol 2002; 30(6): 419-423.
60. Kuehn MH, Stone EM, Hageman GS. Organization of the human IMPG2 gene and its evaluation as a candidate gene in age-related macular degeneration and other retinal degenerative disorders. Invest Ophthalmol Vis Sci 2001; 42(13): 3123-3129.
61. Shastry BS, Trese MT. Evaluation of the peripherin/RDS gene as a candidate gene in families with age-related macular degeneration. Ophthalmologica 1999; 213(3): 165-170.
62. Akimoto A, Akimato M, Kuroiwa S, Kikuchi T, Yoshimura N. Lack of association of mutations of the bestrophin gene with age-related macular degeneration in non-familial Japanese patients. Graefes Arch Clin Exp Ophthalmol 2001; 239(1): 66-68.
63. Seddon JM, Afshari MA, Sharma S, Bernstein PS, Chong S, Hutchinson A et al. Assessment of mutations in the Best macular dystrophy (VMD2 gene in patients with adult-onset foveomacular vitelliform dystrophy, age-related maculopathy, and bull's-eye maculopathy. Ophthalmology 2001; 108(11): 2060-2067.
64. Kramer F, White Y, Pauleikhoff D, Gehrig A, Passmore L, Rivera A et al. Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration. Eur J Hum Genet 2000; 8(4):286-292.
65. Kuroiwa S, Kojima H, Kikuchi T, Yoshimura N. ATP binding cassette transporter retina genotypes and age related macular degeneration: An analysis on exudative non-familial Japanese patients. Br J Ophthalmol 1999; 83(5): 613-615.
66. Allikmets R. Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium. Am J Hum Genet 2000; 67(2): 487-491.
67. Fuse N, Suzuki T, Wada Y, Yoshida M, Shimura M, Abe T et al. Molecular genetic analysis of ABCR gene in Japanese dry form age-related macular degeneration. Jpn J Ophthalmol 2000; 44(3): 245-249.
68. Rivera A, White Y, Stohr H, Steiner K, Hemmrich N, Grimm T et al. A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration. Am J Hum Genet 2000; 67(4): 800-813.
69. Souied EH, Ducroq D, Rozet JM, Gerber S, Perrault I, Munnich A et al ABCR gene analysis in familial exudative age-related macular degeneration. Invest Ophthalmol Vis Sci 2000; 41(1): 244-247.
70. Guymer RH, Heon E, Lotery AJ, Munier FL, Schorderet DF, Baird PN et al. Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration. Arch Ophthalmol 2001; 119(5): 745-751.
71. Shroyer NF, Lewis RA, Yatsenko, AN, Wensel TG, Lupski JR. Cosegregation and functional analysis of mutant ABCR (ABCA4) alleles in families that manifest both Stargardt disease and age-related macular degeneration. Hum Mol Genet 2001; 10(23): 2671-2678.
72. Webster AR, Heon E, Lotery AJ, Vandenburgh K, Casavant TL, Oh KT et al. An analysis of allelic variation in the ABCA4 gene. Invest Ophthalmol Vis Sci 2001; 42(6): 1179-1189.
73. Bernstein PS, Leppert M, Singh N, Dean M, Lewis RA, Lupski JR et al Genotype-phenotype analysis of ABCR variants in macular degeneration probands and siblings. Invest Ophthalmol Vis Sci 2002; 43 (2): 466-473.
74. Baum L, Chan WM, Li WY, Lam DS, Wang PB, Pang CP. ABCA4 sequence variants in Chinese patients with age-related macular degeneration or Stargardt's disease. Ophthalmologica 2003; 217(2): 111-114.
75. Schmidt S, Postel EA, Agarwal A, Allen Jr IC, Walters SN, De la Paz MA et al. Detailed analysis of allelic variation in the ABCA4 gene in age-related maculopathy. Invest Ophthalmol Vis Sci 2003; 44 (7): 2868-2875.
76. Edwards AO, Ritter III R, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science 2005; 308(5720): 421-424.
77. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308(5720): 385-389.
78. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI et al. From The Cover: A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration 10.1073/pnas.0501536102. Proc Natl Acad Sci USA 2005; 102(20): 7227-7232.
79. Souied EH, Leveziel N, Richard F, Dragon Durey MA, Coscas G, Soubrane G et al. Y402 H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population. Mol Vis 2005; 11: 1135-1140.
80. Magnusson KP, Duan S, Sigurdsson H, Petursson H, Yang Z, Zhao Y et al CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med 2006; 3(1): E5.
81. Schultz DW, Klein ML, Humpert AJ, Luzier CW, Persun V, Schain M et al Analysis of the ARMD1 locus: Evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration ih a large family. Hum Mol Genet 2003; 12(24): 3315-3323.
82. Abecasis GR, Yashar BM, Zhao Y, Ghiasvand NM, Zareparsi S, Branham KE et al. Age-related macular degeneration: A high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease. Am J Hum Genet 2004; 74(3): 482-494.
83. Iyengar SK, Song D, Klein BE, Klein R, Schick JH, Humphrey J et al Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am J Hum Genet 2004; 74(1): 20-39.
84. Tuo J, Smith BC, Bojanowski CM, Meleth AD, Gery I, Csaky KG et al. The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. Faseb J 2004; 18(11): 1297-1299.
85. Churchill AJ, Carter JG, Lovell HC, Ramsden C, Turner SJ, Yeung A et al. VEGF polymorphisms are associated with neovascular age-related macular degeneration. Hum Mol Genet 2006; 15(19): 2955-2961.
86. Ayyagari R, Zhang K, Hutchinson A, Yu Z, Swaroop A, Kakuk LE et al Evaluation of the ELOVL4 gene in patients with age-related macular degeneration. Ophthal Genet 2001; 22(4): 233-239.
87. Kimura K, Isashiki Y, Sonoda S, Kakiuchi-Matsumoto T, Ohba N. Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration. Am J Ophthalmol 2000; 130(6): 769-773.
88. Ikeda T, Obayashi H, Hasegawa G, Nakamura N, Yoshikawa T, Imamura Y et al. Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factors for exudative age-related macular degeneration. Am J Ophthalmol 2001; 132(2): 191-195.
89. Hamdi HK, Reznik J, Castellon R, Atilano SR, Ong JM, Udar N et al. Alu DNA polymorphism in ACE gene is protective for age-related macular degeneration. Biochem Biophys Res Commun 2002; 295(3): 668-672.
90. Gorin MB, Breitner JC, De Jong PT, Hageman GS, Klaver CC, Kuehn MH et al. The genetics of age-related macular degeneration. Mol Vis 1999; 5: 29.
91. Pang CP, Baum L, Chan WM, Lau TC, Poon PM, Lam DS. The apolipoprotein E ε4 allele is unlikely to be a major risk factor of age-related macular degeneration in Chinese. Ophthalmologica 2000; 214(4): 289-291.
92. Simonelli F, Margaglione M, Testa F, Cappucci G, Manitto MP, Brancato R et al. Apolipoprotein E polymorphisms in age-related macular degeneration in an Italian population. Ophthal Res 2001; 33 (6): 325-328.
93. Schmidt S, Klaver C, Saunders A, Postel E, De La Paz M, Agarwal A et al. A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy. Ophthalmic Genet 2002; 23(4): 209-223.
94. Baird PN, Guida E, Chu DT, Vu HT, Guymer RH. The ε2 and ε4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 2004; 45(5 : 1311-1315.
95. Wong TY, Shankar A, Klein R, Bray MS, Couper DJ, Klein BE et al. Apolipoprotein E gene and early age-related maculopathy: The Atherosclerosis Risk in Communities Study. Ophthalmology 2006; 113(2): 255-259.
96. Zurdel J, Finckh U, Menzer G, Nitsch RM, Richard G. CST3 genotype associated with exudative age related macular degeneration. Br J Ophthalmol 2002; 86(2): 214-219.
97. Fiotti N, Pedio M, Battaglia Parodi M, Altamura N, Uxa L, Guarnieri G et al. MMP-9 microsatellite polymorphism and susceptibility to exudative form of age-related macular degeneration. Genet Med 2005; 7(4): 272-277.